Last update 20 Mar 2025

Octotiamine/Riboflavin/Pyridoxine Hydrochloride/Cyanocobalamin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Octotiamine/Riboflavin/Pyridoxine/Cyanocobalamin, Neurovitan
+ [1]
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseMouth and Tooth Diseases+ [1]
Active Indication
ArthralgiaAvitaminosisFacial Paralysis+ [3]
Inactive Indication
AnemiaCervicobrachial syndromeHerpes Zoster+ [2]
Originator Organization
LTL Pharma Co., Ltd.LTL Pharma Co., Ltd.
Active Organization
LTL Pharma Co., Ltd.LTL Pharma Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (30 Jun 1966),
AnemiaArthralgiaAvitaminosis+ [8]
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC17H20N4O6
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N
CAS Registry83-88-5
View All Structures (4)

Related

100 Clinical Results associated with Octotiamine/Riboflavin/Pyridoxine Hydrochloride/Cyanocobalamin
Login to view more data
100 Translational Medicine associated with Octotiamine/Riboflavin/Pyridoxine Hydrochloride/Cyanocobalamin
Login to view more data
100 Patents (Medical) associated with Octotiamine/Riboflavin/Pyridoxine Hydrochloride/Cyanocobalamin
Login to view more data
100 Deals associated with Octotiamine/Riboflavin/Pyridoxine Hydrochloride/Cyanocobalamin
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Arthralgia
Japan
LTL Pharma Co., Ltd.LTL Pharma Co., Ltd.
30 Jun 1966
Avitaminosis
Japan
LTL Pharma Co., Ltd.LTL Pharma Co., Ltd.
30 Jun 1966
Facial Paralysis
Japan
LTL Pharma Co., Ltd.LTL Pharma Co., Ltd.
30 Jun 1966
Myalgia
Japan
LTL Pharma Co., Ltd.LTL Pharma Co., Ltd.
30 Jun 1966
Neuralgia
Japan
LTL Pharma Co., Ltd.LTL Pharma Co., Ltd.
30 Jun 1966
Neuritis
Japan
LTL Pharma Co., Ltd.LTL Pharma Co., Ltd.
30 Jun 1966
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free